Beckman Coulter Life Sciences to present NGS technologies at American Society of Human Genetics Annual Meeting

Lab automation company Beckman Coulter Life Sciences has announced that it will return to the American Society of Human Genetics (ASHG) annual meeting on October 25-29 in Los Angeles to display its NGS technologies.

At booth 2037, the company will showcase its instruments and provide one-on-one demonstrations to demonstrate how its technologies can optimize next-generation sequencing (NGS) workflows in low- to high-throughput labs.

At ASHG, the company will explain its vision for how to boost the efficiency of NGS automation at a range of reaction volumes. It will also demonstrate how its technology can automate workflows and generate high-quality sequencing data.

Beckman Coulter Life Sciences will display its NGS suite, including the Biomek NGeniuS Next Generation Library Prep System, the Echo 525 Acoustic Liquid Handler and the Biomek i5 Automated Workstation. The company will also showcase its NGS cleanup reagents and the EMnetik System for plasmid pr…

Read more
  • 0

Beckman Coulter Life Sciences names Suzanne Foster as president 

Lab automation specialist Beckman Coulter Life Sciences has appointed Cardinal Health veteran Suzanne Foster as president.

Foster served as Cardinal Health’s President Health-at-Home subsidiary from January 2020 to March 2022.

She has more than 25 years of experience in the healthcare industry, and also sits on the boards of several companies.

Foster has also served as the Stanley Black & Decker’s president of healthcare and worked for ten years as the general manager of Medtronic’s advanced energy unit.

“I believe a significant step forward can be made by evolving workflows,” Foster wrote in an email. “Finding solutions that make things as clear, accurate, and efficient as possible will certainly make the workload on laboratory staff more manageable.”

Suzanne Foster

Foster noted that she has repeatedly heard the topic of automation come up in conversations with customer…

Read more
  • 0

Beckman Coulter Life Sciences wins IVDR for flow cytometry reagents

Image courtesy of Beckman Coulter

Beckman Coulter Life Sciences (Indianapolis) has received an EU Quality Management System Certificate under the In Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR) for more than 200 flow cytometry reagents manufactured at its Marseille, France facility.

In May 2022, IVDR 2017/746 will replace the In Vitro Diagnostics Directive (98/79/EC) (IVDD), which has been in place since 1993.

Beckman Coulter Life Sciences notes that it has prepared for IVDR 2022 for more than four years, enlisting multiple teams in the effort.

“We have worked to ensure our existing CE-IVD portfolio, including reagents, kits, software and instruments remain compliant to meet the new regulation,” said Dr. Mario Koksch, vice president and general manager of the company’s flow cytometry business unit. “As IVDR compliance also requires significant effort from individual laboratories,…

Read more
  • 0

Beckman Coulter wins FDA EUA for COVID-19 IgG II antibody test

Beckman Coulter today received FDA emergency use authorization for its Access SARS-CoV-2 IgG II antibody test.

The semi-quantitative assay measures the level of antibodies in response to a previous SARS-CoV-2 infection and can provide qualitative and numerical results of antibodies in arbitrary units.

Lenco Diagnostic Laboratories in New York City is one of the first labs to offer the test in its city and the trial-state metropolitan area, according to Beckman Coulter.

“To help in the fight against COVID-19, it is important that we partner with a company that has the reputation, quality, and testing accuracy like Beckman Coulter in meeting the needs of the people of New York,” Robert Boorstein, medical director at Lenco Diagnostics Laboratories, said in a news release. “This next step in COVID-19 antibody testing creates a pathway in helping us establish a quantitative baseline of different antibody levels and determine how a patient…

Read more
  • 0